Benign prostatic hyperplasia (BPH), or an enlarged prostate, can restrict urine flow and sometimes cause complications such as urinary retention, infection, or kidney issues in men 50 years of age and older. Medication is often the primary choice of treatment among these patients, but some patients do not respond, have side effects, or are not interested in taking medications.
Englewood Health’s renowned team of urologists specializes in the treatment of benign prostatic hyperplasia, among other urologic conditions including cancer, kidney stones, diseases of the prostate, bladder, and kidneys, and other general urology disorders.
To treat BPH, the team offers several treatment options including the UroLift System, a minimally invasive option that provides an alternative to tissue-removal surgery with fewer side effects.
“We are continuously innovating and advancing our treatment options available to patients,” said Dr. Maz Ganat, program director of urologic oncology at The Lefcourt Family Cancer Treatment and Wellness Center. “UroLift is a less invasive option with a quicker recovery time and very few side effects when performed in appropriate men. In most cases patients can go home the same day they have the procedure.”
With the use of the latest technology, including minimally invasive and surgical robotic techniques and MRI-ultrasound fusion-guided prostate biopsy, the urology team at Englewood Health works collaboratively with each patient to determine the care plan that is right for them, to provide thoughtful and thorough care, and to ensure the best possible outcomes.
To learn more or schedule an appointment with a urologist, call 201-608-2849.
Posted on November 3, 2020